Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy

Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy

The tumor microenvironment (TME) plays a crucial role in cancer progression and recent evidence has clarified its clinical significance in predicting outcomes and efficacy. However, there are no studies on the systematic analysis of TME characteristics in bladder cancer. In this study, we comprehens...

Full description

Bibliographic Details
Main Authors:	Xingyu Chen, Haotian Chen, Dong He, Yaxin Cheng, Yuxing Zhu, Mengqing Xiao, Hua Lan, Zhanwang Wang, Ke Cao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Immunology
Subjects:	bladder cancer tumor microenvironment immune checkpoint immunotherapy tumor immune dysfunction and exclusion
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.672158/full

Similar Items

Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
by: I-Tsu Chyuan, et al.
Published: (2021-03-01)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
by: Ruibin Yi, et al.
Published: (2020-08-01)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)

Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer
by: Xingyu Chen, et al.
Published: (2020-06-01)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
by: Rui Cao, et al.
Published: (2021-09-01)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
by: Mengjia Huang, et al.
Published: (2021-08-01)

Effect of NCOR1 Mutations on Immune Microenvironment and Efficacy of Immune Checkpoint Inhibitors in Patient with Bladder Cancer
by: Anqi Lin, et al.
Published: (2021-03-01)

Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors
by: Kerstin Kapp, et al.
Published: (2019-12-01)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
by: Rachael M. Zemek, et al.
Published: (2020-02-01)

The regulation of immune checkpoints by the hypoxic tumor microenvironment
by: Min Hu, et al.
Published: (2021-05-01)

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
by: Jingyu Zang, et al.
Published: (2021-05-01)

Targeting immune checkpoints in hematological malignancies
by: Basit Salik, et al.
Published: (2020-08-01)

Dendritic Cell-targeted approaches to modulate immune dysfunction in the Tumor Microenvironment
by: Anne eGallois, et al.
Published: (2013-12-01)

Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors
by: Zihui Li, et al.
Published: (2020-11-01)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
by: Muhammad Zaeem Noman, et al.
Published: (2019-09-01)

Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
by: Xiaoying Li, et al.
Published: (2021-10-01)

Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
by: Jingyi Zhou, et al.
Published: (2021-02-01)

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
by: Barbara Seliger
Published: (2019-05-01)

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
by: Alexandre Perrier, et al.
Published: (2020-07-01)

Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy
by: Kamila Wojas-Krawczyk, et al.
Published: (2021-08-01)

Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
by: Seyed Hossein Kiaie, et al.
Published: (2021-05-01)

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
by: Xiaolei Li, et al.
Published: (2018-02-01)

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
by: Bai X, et al.
Published: (2019-11-01)

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
by: Tyler J. Nielsen, et al.
Published: (2021-03-01)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
by: Yuli Jian, et al.
Published: (2021-03-01)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
by: Sijia Ren, et al.
Published: (2021-06-01)

Grand Challenge « Tumor immunology, towards a success story ? »
by: Catherine eSautès-Fridman
Published: (2015-02-01)

New Insights into the Role of Autophagy in Tumor Immune Microenvironment
by: Chia-Jung Li, et al.
Published: (2017-07-01)

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
by: Tong Fu, et al.
Published: (2021-06-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Next generation of immune checkpoint inhibitors and beyond
by: Julian A. Marin-Acevedo, et al.
Published: (2021-03-01)

The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma
by: Hong Yuan, et al.
Published: (2021-03-01)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
by: Nicola E. Annels, et al.
Published: (2020-02-01)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01)

Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
by: Nicole E. Scharping, et al.
Published: (2016-12-01)

Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby
by: Ji-Eun Irene Yum, et al.
Published: (2021-04-01)

Immunotherapy in cholangiocarcinoma: From concept to clinical trials
by: Wen-Yan Yao, et al.
Published: (2021-06-01)

Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
by: Yu Chen, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_9uqsc6bf7h3dd1tnu8iq1qo7ek